AI
LUMO

Acuitas Investments’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Acuitas Investments’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-141,435
Closed -$328K – 129
2024
Q2 		$328K Buy
141,435
+746
+0.5% +$1.93K 0.18% 107
2024
Q1 		$397K Buy
140,689
+15,407
+12% +$45.7K 0.2% 105
2023
Q4 		$394K Buy
125,282
+40
+0% +$136 0.21% 105
2023
Q3 		$413K Sell
125,242
-28,625
-19% -$89.2K 0.24% 91
2023
Q2 		$508K Buy
+153,867
New +$543K 0.3% 86

Other funds holding LUMO

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Acuitas Investments's LUMO Position: Q3 2024 in Review

Acuitas Investments sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 141,435 shares — an estimated $328K sold.

Acuitas Investments first reported a position in LUMO in Q2 2023 and held it in 5 quarters. The position peaked at $508K in Q2 2023. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

  • Acuitas Investments reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Acuitas Investments sold 141,435 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $328K.
  • Acuitas Investments first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • Acuitas Investments's Lumos Pharma, Inc. Common Stock position peaked at $508K in Q2 2023.
  • 28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on Acuitas Investments's 13F filing for Q3 2024, filed 7 Nov 2024.